VIVOS INC. Files 8-K: Agreements, Officer Changes, Financials
Ticker: RDGL · Form: 8-K · Filed: Mar 25, 2024 · CIK: 1449349
| Field | Detail |
|---|---|
| Company | Vivos Inc (RDGL) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $295,500, $10,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, officer-changes, director-changes, financials
TL;DR
VIVOS INC. filed an 8-K detailing a material agreement, officer/director changes, and financial statements.
AI Summary
On December 19, 2023, VIVOS INC. entered into a material definitive agreement. The company also reported the departure of directors or certain officers, the election of directors, and the appointment of certain officers, along with compensatory arrangements for certain officers. Financial statements and exhibits were also filed.
Why It Matters
This filing indicates significant corporate actions including new agreements and changes in leadership, which could impact the company's strategic direction and operational stability.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and changes in corporate officers/directors, which can introduce uncertainty and potential shifts in strategy.
Key Players & Entities
- VIVOS INC. (company) — Registrant
- December 19, 2023 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 719 Jadwin Avenue, Richland, WA 99352 (address) — Principal executive offices
FAQ
What was the specific nature of the material definitive agreement entered into by VIVOS INC. on December 19, 2023?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
Which directors or officers departed from VIVOS INC. on or around December 19, 2023?
The filing mentions the departure of directors or certain officers, but does not name the specific individuals involved in the provided text.
Who were the newly elected directors or appointed officers of VIVOS INC. as reported in this 8-K?
The filing states that directors were elected and officers were appointed, but the names of these individuals are not specified in the provided text.
What is the primary business of VIVOS INC. according to its SIC code?
VIVOS INC. is classified under SIC code 3841, which corresponds to 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS'.
What is the fiscal year end for VIVOS INC.?
The fiscal year end for VIVOS INC. is December 31st (1231).
Filing Stats: 666 words · 3 min read · ~2 pages · Grade level 12 · Accepted 2024-03-22 20:38:38
Key Financial Figures
- $295,500 — l receive: (i) an annual base salary of $295,500; (ii) a grant of 20,000 shares of restr
- $10,000 — eceive an annual bonus in the amount of $10,000 per quarter upon the satisfaction of co
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex10-12.htm (EX-10.12) — 148KB
- 0001493152-24-011040.txt ( ) — 381KB
- rdgl-20231219.xsd (EX-101.SCH) — 3KB
- rdgl-20231219_lab.xml (EX-101.LAB) — 33KB
- rdgl-20231219_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
01
Item 1.01 Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.12 Amended and Restated Employment Agreement between Vivos Inc. and Michael Korenko. Dated December 19, 2023, with a deemed effective date of January 1, 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. VIVOS INC. Date: March 22, 2024 By: /s/ Michael K. Korenko Name: Michael K. Korenko Title: Chief Executive Officer